RT @CochraneCGF: We are uncertain if long‐term GnRH agonist therapy affects live birth rate, complication rate, clinical #pregnancy rate an…
RT @OmarRawi89: We need more research and quality data 👇🏼 #EndometriosisAwarenessMonth
We need more research and quality data 👇🏼 #EndometriosisAwarenessMonth
There is too much we don't know yet #EndometriosisAwarenessMonth
We are uncertain if long‐term GnRH agonist therapy affects live birth rate, complication rate, clinical #pregnancy rate and pregnancy loss rate compared to standard #IVF or #ICSI in women with #endometriosis https://t.co/ByDj9PZIgo @CochraneLibrary #Endo
We are uncertain as to whether long‐term GnRH agonist therapy impacts on the live birth rate or the complication rate compared to standard #IVF or #ICSI in #women with #endometriosis https://t.co/Ch99VZVexj #EndometriosisAwarenessMonth
#Désensibilisation à long terme (ou down-regulation) de l’#hypophyse, avant la #FIV (fécondation in vitro) chez les femmes atteintes d'#endométriose : https://t.co/hrHz0jVJKA
First #review on #endometriosis published! #weekend well deserved
New #Cochrane #review published! We are uncertain if long-term GnRH agonist therapy (pituitary down‐regulation) improves #fertility outcomes in #women with #endometriosis compared to standard #IVF or #ICSI https://t.co/EqcJC8BvdY https://t.co/5PjF4rLTTb